GlassScriptPhysician profile
Jaymee Delaney
NPI 1003864687
$604.48
in general payments reported to CMS, 2019-2025
11 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $216 · 2020: $69.16 · 2021: $47.91 · 2022: $271.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Zimmer Biomet Holdings, INC. | $142.60 | 2019 | |
| Providence Medical Technology, INC. | $130.70 | 2022 | |
| Medtronic, INC. | $56.20 | 2022 | |
| Si-Bone, INC. | $54.07 | 2021-2022 | |
| Surgalign Spine Technologies, INC. | $49.91 | 2020 | |
| Convatec INC. | $37.66 | 2019 | |
| Novo Nordisk INC | $36.21 | 2019-2021 | |
| Currax Pharmaceuticals LLC | $31.96 | 2022 | |
| Stryker Corporation | $29.67 | 2022 | |
| Baudax Bio INC. | $19.25 | 2020 | |
| Djo, LLC | $16.25 | 2019 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jaymee Delaney listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.